Organon & Co. (OGN)
13.35
+0.03
(+0.23%)
USD |
NYSE |
May 08, 16:00
13.30
-0.05
(-0.37%)
After-Hours: 20:00
Organon Total Assets (Quarterly) : 13.00B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 128.68B |
| Eli Lilly & Co. | 116.58B |
| Ligand Pharmaceuticals, Inc. | 1.532B |
| Veradermics, Inc. | 154.47M |
| Johnson & Johnson | 200.89B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.09B |
| Shareholders Equity (Quarterly) | 903.00M |
| Debt to Equity Ratio | 9.490 |
| Current Ratio | 1.973 |
| Net Debt Paydown Yield | 5.94% |